Another Covid-19 study is hitting the breaks as a Swiss biotech is pausing its Phase II trial in patients hospitalized with Covid-19. Kinarus Therapeutics announced on Friday that the Data and Safety Monitoring Board (DSMB) […]
CARLSBAD, Calif. and BRISBANE, Australia, Sept. 30, 2022 /PRNewswire/ — ImpediMed Limited (ASX: IPD), a global medical technology company using bioimpedance spectroscopy (BIS) to generate powerful data to maximize patient health, today announced two poster […]
RICHMOND, Va., Sept. 30, 2022 /PRNewswire/ — Indivior PLC (LON: INDV) today announced that at the General Meeting of Shareholders held earlier today, shareholders approved the resolution to proceed with an Additional Listing on a […]
NEWTOWN SQUARE, Pa., Sept. 30, 2022 /PRNewswire/ — Kibow Biotech, Inc., a clinical-stage biotechnology company developing live biotherapeutics that target the dysbiosis in patients with CKD, today celebrated a 25-year legacy of dedication to improving […]
WATERTOWN, Mass.–(BUSINESS WIRE)–EnPlusOne Biosciences, Inc., a biotechnology company harnessing the power of enzymes to synthesize RNA oligonucleotides, today formally launched with $12 million in seed financing. The round was led by Northpond Ventures with participation […]
Nenad Grmusa Nenad Grmusa was “really happy” at Takeda, where he’d been for more than a decade in various R&D strategy and finance positions. However, the more he learned about DEM BioPharma, the more intrigued […]
Health care systems look to wealthy donors, often after saving their lives. Click here to view original post Click here to view original post
For a while, scientists thought the trillions of microbes on our bodies lived in landscapes connected to the outside world — our skin, hair, and gut — but research in the last few years has […]
That’s down from the $500 cost today. These new sequencers — called NovaSeq X and NovaSeq X Plus — are expected to begin shipping to customers early next year. Click here to view original post
Amylyx Pharmaceuticals Inc. has won its first approval from the U.S. Food and Drug Administration for a drug designed to treat amyotrophic lateral sclerosis, or ALS. Click here to view original post
© 2022 Biotech Networks, LLC
